Loading...

APC anti-mouse CD206 (MMR) Antibody

Pricing & Availability
Clone
C068C2 (See other available formats)
Regulatory Status
RUO
Other Names
MMR (macrophage mannose receptor), MR (mannose receptor), MRC1
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
C068C2_APC_1_082911
Thioglycollate-elicited BALB/c peritoneal macrophages were surface stained with CD107b (Mac-3) PE, and then intracellularly stained with CD206 (clone C068C2) APC (top) or rat IgG2a, κ APC isotype control (bottom).
  • C068C2_APC_1_082911
    Thioglycollate-elicited BALB/c peritoneal macrophages were surface stained with CD107b (Mac-3) PE, and then intracellularly stained with CD206 (clone C068C2) APC (top) or rat IgG2a, κ APC isotype control (bottom).
  • C068C2_APC_2_082911
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
141707 25 µg 105€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
141708 100 µg 237€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD206, also known as mannose receptor (MR), is a 175 kD type I membrane protein. It is a pattern recognition receptor (PRR) belonging to the C-type lectin superfamily. MR is expressed on macrophages, dendritic cells, Langerhans cells, and hepatic or lymphatic endothelial cells. MR recognizes a range of microbial carbohydrates bearing mannose, fucose, or N-acetyl glucosamine through its C-type lectin-like carbohydrate recognition domains, sulfated carbohydrate antigens through its cysteine-rich domain, and collagens through its fibronectin type II domain. MR mediates endocytosis and phagocytosis as well as activation of macrophages and antigen presentation. It plays an important role in host defense and provides a link between innate and adaptive immunity. Recently, MR on lymphatic endothelial cells was found to be involved in leukocyte trafficking and a contributor to the metastatic behavior of cancer cells. It suggests that MR may be a potential target in controlling inflammation and cancer metastasis by targeting the lymphatic vasculature.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Recombinant mouse CD206 (MMR)
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested
FC - Verified
Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone C068C2 recognizes a region similar to clone MR5D3, based on the ability of the clones to block each other. Additional reported applications (for the relevant formats) include: spatial biology (IBEX)4,5.

Application References

(PubMed link indicates BioLegend citation)
  1. Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed
  2. Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed
  3. Yang X, et al. 2015. PNAS. 112:2900. PubMed
  4. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  5. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Jiang Z, et al. 2021. J Clin Invest. 131: . PubMed
  2. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  3. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  4. Liu C, et al. 2022. Regen Ther. 21:192. PubMed
  5. Liu J, et al. 2017. Mucosal Immunol. 10.1038/mi.2016.139. PubMed
  6. Wang C, et al. 2018. J Pharmacol Exp Ther. 365:72. PubMed
  7. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  8. El-Hindi K, et al. 2022. Int J Mol Sci. 23:. PubMed
  9. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  10. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  11. Jeong J, et al. 2017. Sci Rep. 7:39848. PubMed
  12. Poh AR, et al. 2017. Cancer Cell. 31:563. PubMed
  13. Liu C, et al. 2019. J Transl Med. 17:300. PubMed
  14. Zhang X, et al. 2017. J Cell Mol Med. 10.1111/jcmm.13329. PubMed
  15. Zhang J, et al. 2021. Front Cardiovasc Med. 8:737652. PubMed
  16. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  17. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  18. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  19. Giordano C, et al. 2014. Hum Mol Genet. . PubMed
  20. Mylonas K, et al. 2015. Immunobiology. 220: 924-933. PubMed
  21. Cardona S, et al. 2015. ASN Neuro. 7: 1759091415608204. PubMed
  22. Tahiri H, et al. 2016. Sci Rep. 6:37391. PubMed
  23. Kurelac I, et al. 2019. Nat Commun. 10:903. PubMed
  24. Chang CF, et al. 2017. Neurobiol Dis. 103:54. PubMed
  25. Pilch Z, et al. 2018. Cancer Immunol Res. 6:930. PubMed
  26. Nawaz A, et al. 2022. Nat Commun. 13:7058. PubMed
  27. Zhang L, et al. 2022. Acta Pharm Sin B. 12:3427. PubMed
  28. Chen X, et al. 2021. Cell Death Differ. 28:1237. PubMed
  29. Trott DW, et al. 2021. Geroscience. 43:1331. PubMed
  30. Yuan Q, et al. 2021. Cell Reports. 34(5):108724. PubMed
  31. Young JA, et al. 2020. Journal of Neuroendocrinology. e12854.. PubMed
  32. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  33. Li S, et al. 2021. Ann Transl Med. 9:1644. PubMed
  34. Chen F, et al. 2022. Evid Based Complement Alternat Med. 2022:1240242. PubMed
  35. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  36. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  37. Li Q, et al. 2021. Brain Behav Immun. 94:437. PubMed
  38. Wada N, et al. 2020. Mol Metab. 37:100988. PubMed
  39. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
  40. Motoyama S, et al. 2020. Cells. :9. PubMed
  41. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  42. Liao Y, et al. 2020. Mol Ther. 28:855. PubMed
  43. Hu M, et al. 2022. Can Respir J. 2022:5802938. PubMed
  44. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  45. Qiu J, et al. 2016. Sci Rep. 6:39407. PubMed
  46. Lasky C, et al. 2015. Infect Immun . 83: 2627 - 2635. PubMed
  47. van Dierendonck XAMH, et al. 2020. Cell Reports. 30(6):1811-1822. PubMed
  48. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  49. Yan J, et al. 2018. Nat Commun. 9:33. PubMed
  50. Xie Z, et al. 2021. Open Life Sci. 16:653. PubMed
  51. Wu L, et al. 2022. Front Cell Dev Biol. 9:684842. PubMed
  52. Chen X, et al. 2022. J Appl Oral Sci. 30:e20220316. PubMed
  53. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  54. Zhang P, et al. 2022. BMC Med. 20:435. PubMed
  55. Xiao Y, et al. 2022. Clin Transl Med. 12:e1071. PubMed
  56. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  57. Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed
  58. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  59. Taguchi K, et al. 2015. J Urol. . PubMed
  60. Calvo B, et al. 2020. IBRO Rep. 8:36. PubMed
  61. Jin RM, et al. 2017. J Immunol. 198:352. PubMed
  62. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  63. Mallampalli RK, et al. 2021. Front Immunol. 12:735576. PubMed
  64. Taguchi K, et al. 2014. J Am Soc Nephrol. 25:1680. PubMed
  65. Rios-Doria J, et al. 2021. Front Oncol. 10:598477. PubMed
  66. Ayala TS, et al. 2019. Sci Rep. 9:11447. PubMed
  67. Xu M, et al. 2022. Genes Dis. 9:429. PubMed
  68. Ganesan R, et al. 2020. FASEB J. 34:15888. PubMed
  69. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  70. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  71. Xue N, et al. 2017. Sci Rep. 7:39011. PubMed
  72. Lee JY, et al. 2020. Nat Commun. 11:2358. PubMed
  73. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  74. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  75. Wang Q, et al. 2018. Nat Commun. 9:559. PubMed
  76. Zhou X, et al. 2022. Front Pharmacol. 13:872188. PubMed
  77. Moya-Pérez A, et al. 2015. PLoS One. 10: 0126976. PubMed
  78. De Simone G, et al. 2021. Immunity. :. PubMed
  79. Rhys HI, et al. 2018. EBioMedicine. 29:60. PubMed
  80. Sasaki T, et al. 2020. Cell Reports. 28(1):202-217.e7.. PubMed
  81. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  82. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  83. Zhang S, et al. 2021. J Inflamm Res. 14:4915. PubMed
  84. Sun M, et al. 2021. J Immunother Cancer. 9:. PubMed
  85. Fan Q, et al. 2021. Bioact Mater. 6:4014. PubMed
  86. Blriot C, et al. 2021. Immunity. :. PubMed
  87. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  88. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  89. Luo J et al. 2018. Immunity. 49(1):107-119 . PubMed
  90. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  91. Trott DW, et al. 2021. J Physiol. 599:3973. PubMed
  92. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  93. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  94. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  95. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  96. Di Mitri D, et al. 2019. Cell Rep. 28:2156. PubMed
  97. Fujimoto N, et al. 2020. PLoS Biol. 18:e3000704. PubMed
  98. Remmerie A, et al. 2020. Immunity. 53:641. PubMed
  99. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  100. Guo D, et al. 2022. Bone Res. 10:45. PubMed
  101. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  102. Li ZL, et al. 2021. Mol Ther Nucleic Acids. 25:502. PubMed
  103. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  104. Zhang Y, et al. 2020. Mol Med Rep. 22:534. PubMed
  105. Kiyohara H, et al. 2018. Cell Mol Gastroenterol Hepatol. 7:135. PubMed
  106. Gao Z, et al. 2022. J Inflamm Res. 15:3337. PubMed
  107. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  108. He H, et al. 2012. Blood. 120:3152. PubMed
  109. Dai K, et al. 2015. J Leukoc Biol. 98: 1071 - 1080. PubMed
  110. Settelmeier S, et al. 2020. PLoS One. 15:e0233261. PubMed
  111. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  112. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  113. Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed
  114. Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
  115. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  116. Roux C, et al. 2021. Antioxidants (Basel). 10:. PubMed
  117. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  118. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  119. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  120. Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed
  121. Tang PC, et al. 2022. Adv Sci (Weinh). 9:e2101235. PubMed
  122. Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed
  123. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  124. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  125. Lee SH, et al. 2018. J Exp Med. 215:357. PubMed
  126. Piirainen S, et al. 2021. Glia. 69:2459. PubMed
  127. Catrysse L, et al. 2021. Cell Rep. 36:109748. PubMed
  128. Zhu Y, et al. 2021. Int J Oral Sci. 13:25. PubMed
  129. Filtjens J, et al. 2021. Nat Commun. 12:2936. PubMed
  130. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  131. Canan C, et al. 2014. J Leukoc Biol. 96:473. PubMed
  132. Lee C, et al. 2020. Front Immunol. 11:77. PubMed
  133. Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed
  134. Song HY, et al. 2021. Mol Ther. S1525-0016:00472-X. PubMed
  135. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  136. Baardman J et al. 2018. Cell reports. 25(8):2044-2052 . PubMed
  137. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  138. Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed
  139. Kurelac I, et al. 2019. J Clin Med. 1.85. PubMed
  140. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  141. Chithanathan K, et al. 2022. Biology (Basel). 11:. PubMed
  142. Ding T, et al. 2021. J Nanobiotechnology. 19:247. PubMed
  143. Andreata F, et al. 2021. STAR Protoc. 2:100831. PubMed
  144. Liu Y, et al. 2019. Am J Physiol Cell Physiol. 317:C762. PubMed
  145. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  146. Nasti A, et al. 2017. Eur J Immunol. 47:2163. PubMed
RRID
AB_10896057 (BioLegend Cat. No. 141707)
AB_10900231 (BioLegend Cat. No. 141708)

Antigen Details

Structure
Type I transmembrane protein, 175 kD, C-type lectin superfamily
Distribution

Macrophages, dendritic cells, Langerhans cells, liver endothelial cells

Function
Pathogen recognition, endocytosis and phagocytosis, antigen presentation
Ligand/Receptor
Antigen containing mannose, fucose, or an N-acetyl glucosamine
Cell Type
Dendritic cells, Endothelial cells, Langerhans cells, Macrophages
Biology Area
Cell Biology, Immunology, Innate Immunity, Signal Transduction
Molecular Family
CD Molecules
Antigen References

1. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501.
2. Apostolopoulos V, et al. 2001. Curr. Mol. Med. 1:469.
3. Burgdorf S, et al. 2006. J. Immunol. 176:6770.
4. McKenzie EJ, et al. 2007. J. Immunol. 178:4975.

Gene ID
17533 View all products for this Gene ID
UniProt
View information about CD206 on UniProt.org

Related FAQs

Why is mouse CD206 stained intracellularly and not via surface staining?

Typically, mouse CD206 surface level is relatively low under normal conditions and so intracellular staining protocol is required to get better signal.

Go To Top Version: 3    Revision Date: 04/04/2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account